Posted on 8月 24, 20218/24/21
CHALLENGING TRADITION: The argument for integrated commercialization to improve operational agility
Posted on 7月 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on 7月 13, 20217/13/21
Case Study: Launching a New Therapy for HER2-Positive Metastatic Breast Cancer
Posted on 7月 12, 20217/12/21
Global Regulations Push Accelerated Approvals, Access and Treatment Distribution: June 2021
Posted on 6月 29, 20216/29/21
A SpaceX Philosophy to Launching in Pharma
Posted on 6月 23, 20216/23/21
Considering a Virtual Advisory Board as a Viable, Cost-Effective Option for PMR Planning
Posted on 6月 23, 20216/23/21
The Rise of Digital Therapeutics Opportunities in China
Posted on 6月 16, 20216/16/21
Global Pharma Heads Into Uncharted Territories in Pricing and Regulation: May 2021
Posted on 6月 15, 20216/15/21
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
Posted on 5月 28, 20215/28/21